What 5G means to the medtech industry beyond tele-robotics.
Corindus Vascular Robotics is at it again.
The Corpath System had done the first in-human telerobotic coronary surgery in December of 2018 in India.
Recently, I had a chance to sit in with Corindus Vascular Robotics and COO, Doug Teany and his team on a 5G test that Corindus had been performing here in the U.S. at Verizon’s Innovation Center in Waltham, Ma. It was connected with a simulated O.R. in Cambridge, Ma, 10 miles away.
While sitting in the Verizon Innovation Center, the ability to tele-robotically watch a surgeon perform as if they were there in the room with their team and the technology will be saving or impacting millions of lives per year, was game-changing, but there was more at play.
5G has a much greater impact on the medtech industry than just tele-robotics.
We are living in an amazing time. The acceleration of technology is mind bending. Sure, 5G is a game changer in patient access around the globe. What 5G means to product development, collaboration, computing storage, cloud-based business models, open relationships in platform development and the wider spectrum of real-time data available to product development teams and scientists will bring about a step-change in product innovation.